 comparison heparin low-dos aspirin adjunct therapi tissu plasminogen activ acut myocardi infarct heparin-aspirin reperfus trial hart background result heparin-aspirin reperfus trial collabor studi intraven heparin oral aspirin adjunct treatment recombin tissu plasminogen activ rt-pa coronari thrombolysi acut myocardi infarct method patient immedi continu intraven heparin bolu immedi daili oral aspirin mg rt-pa mg six-hour period hour onset symptom patenc infarct-rel arteri angiographi hour rt-pa infus frequenc reocclus arteri repeat angiographi day ischem hemorrhag complic hospit stay result time first angiogram percent infarct-rel arteri patient patent percent aspirin group initi patent vessel percent patent day heparin group percent aspirin group signific number hemorrhag event heparin aspirin group recurr ischem event heparin aspirin group similar group conclus coronari patenc rate rt-pa earli concomit system heparin treatment concomit low-dos oral aspirin observ import implic clinic practic design interpret clinic trial coronari thrombolyt therapi